We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

22 hedge funds and large institutions have $3.84M invested in Capricor Therapeutics in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

28% more capital invested

Capital invested by funds: $3.01M → $3.84M (+$836K)

16% more funds holding

Funds holding: 19 → 22 (+3)

0.52% more ownership

Funds ownership: 0.42% → 0.95% (+0.52%)

Holders
22
Holders Change
+3
Holders Change %
+15.79%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Brown Advisory
Brown Advisory
Maryland
+$2.46M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$587K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$103K
4
OAM
Oxford Asset Management
United Kingdom
+$60.3K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$59.4K

Top Sellers

1
Jane Street
Jane Street
New York
-$190K
2
FWM
Frontier Wealth Management
Missouri
-$142K
3
TSS
Two Sigma Securities
New York
-$78K
4
BAM
Belpointe Asset Management
Nevada
-$4.87K
5
JP Morgan Chase
JP Morgan Chase
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
1
Brown Advisory
Maryland
$1.8M +$2.46M +113,676 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.13M +$587K +27,142 +61%
CBA
3
Coastal Bridge Advisors
Connecticut
$188K – – –
BAM
4
Belpointe Asset Management
Nevada
$126K -$4.87K -225 -3%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$121K +$51.7K +2,388 +45%
AA
6
Apriem Advisors
California
$79K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$75K +$103K +4,749 New
Northern Trust
8
Northern Trust
Illinois
$61K +$46.7K +2,157 +126%
Wells Fargo
9
Wells Fargo
California
$56K – – –
GPCM
10
Granite Point Capital Management
Massachusetts
$53K – – –
OAM
11
Oxford Asset Management
United Kingdom
$45K +$60.3K +2,784 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$44K +$59.4K +2,744 New
Citadel Advisors
13
Citadel Advisors
Florida
$16K +$21.7K +1,001 New
HIIFS
14
Harel Insurance Investments & Financial Services
Israel
$11K – – –
Bank of America
15
Bank of America
North Carolina
$10K +$5.41K +250 +63%
BlackRock
16
BlackRock
New York
$9K +$519 +24 +4%
UBS Group
17
UBS Group
Switzerland
$7K +$9.48K +438 New
PA
18
Perceptive Advisors
New York
$6K +$8.66K +400 New
CFN
19
Cordasco Financial Network
Florida
$5K – – –
Deutsche Bank
20
Deutsche Bank
Germany
$4K +$3.9K +180 +150%
FANJ
21
Financial Architects (New Jersey)
New Jersey
$3K – – –
Jane Street
22
Jane Street
New York
– -$190K -6,286 Closed
FWM
23
Frontier Wealth Management
Missouri
– -$142K -4,700 Closed
TSS
24
Two Sigma Securities
New York
– -$78K -2,559 Closed
JP Morgan Chase
25
JP Morgan Chase
New York
– -$4K -200 Closed

CAPR Hedge Fund Activity: Q4 2017 in Review

22 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q4 2017, worth a combined $3.84M — up 28% from $3.01M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CAPR positions and 4 closed out — a net gain of 3 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Brown Advisory, opening a new position worth an estimated $2.46M. The largest seller was Jane Street, exiting entirely with an estimated $190K sold.

  • 22 institutional investors held Capricor Therapeutics (CAPR) as of Q4 2017, up from 19 in Q3 2017.
  • Funds reported $3.84M of Capricor Therapeutics stock for Q4 2017, up 28% quarter-over-quarter.
  • 7 funds opened new Capricor Therapeutics positions in Q4 2017 and 4 closed out, a net change of +3 holders.
  • The largest Capricor Therapeutics buyer in Q4 2017 was Brown Advisory, an estimated $2.46M added.
  • The largest Capricor Therapeutics seller in Q4 2017 was Jane Street, an estimated $190K sold.

Based on aggregated 13F filings for Q4 2017.